Antibiotic therapy effects on lipidFoxidizing Chlamydia Pneumoniae antibodies in coronary heart disease patients
.
Saved in:
| Main Authors: | N. E. Chalyk, P. Ya. Dovgalevsky, V. A. Klochkov, O. M. Anisimova, I. Petyaev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2006-10-01
|
| Series: | Российский кардиологический журнал |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1946 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA
by: P. Ya. Dovgalevsky, et al.
Published: (2016-01-01) -
CHLAMYDIA PNEUMONIAE AS A FACTOR OF CORONARY HEART DISEASE DESTABILIZATION
by: Z. G. Gadjiyeva, et al.
Published: (2003-08-01) -
Clinical diagnostics role of serum Chlamydia pneumoniae antibodies and acute phase proteins in acute coronary syndrome
by: A. M. Pishchukhina, et al.
Published: (2007-08-01) -
Interrelationship of interleukin 6, C-reactive protein and Chlamydia pneumoniae IgG antibodies in patients with acute coronary syndromes
by: Burazor Ivana, et al.
Published: (2008-01-01) -
Chlamydia pneumoniae and Atherosclerosis: The End?
by: LE Nicolle
Published: (2005-01-01)